Study reveals how cancer drug helps to restore immune system's ability to fight tumors https://ift.tt/e1SVswD

A DNA segment known as 9p21, which is frequently deleted in tumours and occurs in 25 per cent-50 per cent of various cancers such melanoma, bladder cancer, mesothelioma, and several brain cancers, is frequently deleted. Long-standing research has shown that malignancies with the 9p21 deletion have worse prognoses for patients and are more resistant to immunotherapies, which are cancer treatments that boost a patient's innate immune system.

from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/G0yMCs1